BIOMERICA INC 10-Q

ITEM 5. OTHER INFORMATION The Company held its Annual Meeting of Stockholders on December 10, 2020, to consider and vote on the proposals set forth in our proxy statement filed with the Securities and Exchange Commission on September 25, 2020. Please refer to the Form 8-K filed on December 11, 2020 for a description of the results of the meeting. ITEM 6. EXHIBITS . The following exhibits are filed or furnished as part of this quarterly report on Form 10-Q: Exhibit No. Description 31.1 * Certification Pursuant to Section 302 of the Sarbanes-Oxley Act — Zackary S. Irani 31.2 * Certification Pursuant to Section 302 of the Sarbanes-Oxley Act — Steve Sloan 32.1 * Certification Pursuant to Section 906 of the Sarbanes-Oxley Act — Zackary S. Irani 32.2 * Certification Pursuant to Section 906 of the Sarbanes-Oxley Act — Steve Sloan 101 Interactive data files pursuant to Rule 405 Regulation S-T, as follows: 101.INS-XBRL Instance Document 101.SCH-XBRL Taxonomy Extension Schema Document 101.CAL-XBRL Taxonomy Extension Calculation Linkbase Document 101.DEF–XBRL Taxonomy Extension Definition Linkbase Document 101.LAB-XBRL Taxonomy Extension Label Linkbase Document 101.PRE-XBRL Taxonomy Extension Presentation Linkbase Document *Filed herewith. 18 Table of Contents SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has fully caused this report to be signed on its behalf by the undersigned thereunto duly authorized. BIOMERICA, INC. Date: January 14, 2021 By: /S/ Zackary S. Irani Zackary S. Irani Chief Executive Officer (Principal Executive Officer) Date: January 14, 2021 By: /S/ Steve Sloan Steve Sloan Chief Financial Officer (Principal Financial Officer) 19